Pharmeuropa: Revision of Residual Solvents Chapter 2.4.24 Published for Comments
Recommendation

Tuesday, 10 November 2026 9 .00 - 17.00 h
On 30 September 2025, the European Pharmacopoeia published in Pharmeuropa 37.4 a fully revised draft of Chapter 2.4.24 Identification and control of residual solvents for public consultation.
According to the briefing note, the revision is mainly editorial, aiming to improve clarity and usability. Key updates include:
- A clearer distinction between non-targeted and targeted analysis approaches.
- Introduction of a separate system suitability solution prepared from a subset of Class 2 solvents.
- Updated chromatograms for Class 2 residual solvents, now also covering cyclopentyl methyl ether and tert-butyl alcohol.
The updated chapter now follows this structure:
- Introduction
- Principle
- Equipment
- Procedure
- Preparation of solutions
- Identification and confirmation of solvents in the substance to be examined (steps 1 and 2)
- Quantitation of identified or specified residual solvents (step 3 – limit test)
The draft text is available on the Pharmeuropa website (login required). Comments can be submitted until 31 December 2025 via the Pharmeuropa platform.
Related GMP News
02.11.2026FDA Warning Letter: When Test Procedures Allow Retesting Until an Acceptable Result is Obtained
21.10.2026EMA Updates Information Page on Bioequivalence Guidelines
21.10.2026BP Publishes new Draft Texts
21.10.2026FDA Identifies Critical Deficiencies in Analytical Testing and CGMP Oversight
07.10.2026Analytical Quality Group Developments May through August 2026
07.10.2026Two New FDA Warning Letters Put OOS Investigations in Focus


